Enzymatica AB (publ) (STO:ENZY)

Enzymatica AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	6.69	33.13	75.21	8.37	50.69	31.62
Cash & Short-Term Investments	6.69	33.13	75.21	8.37	50.69	31.62
Cash Growth	-79.77%	-55.95%	799.02%	-83.49%	60.31%	31.65%
Accounts Receivable	10.85	10	12.09	11.34	14.23	16.32
Other Receivables	5.37	2.15	3.31	3.13	3.48	3.75
Receivables	16.22	12.15	15.4	14.47	17.71	20.07
Inventory	14.06	18.92	16.71	11.5	11.51	12.44
Prepaid Expenses	-	0.83	4.68	4.45	4.94	0.65
Total Current Assets	36.97	65.03	112	38.78	84.85	64.78
Property, Plant & Equipment	21.83	10.37	14.4	16.48	16.4	15.16
Goodwill	-	63.21	63.21	63.21	63.21	63.21
Other Intangible Assets	62.69	0.33	0.66	1.12	1.62	1.99
Long-Term Deferred Tax Assets	1.96	2.41	2.64	2.32	2.32	2.12
Long-Term Deferred Charges	-	0.65	2.33	4	6.02	9.79
Total Assets	123.45	141.98	195.22	125.91	174.41	157.04

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	7	8.75	9.81	7.37	6.67	7.61
Accrued Expenses	-	5.86	5.07	9.51	17.08	19.24
Current Portion of Long-Term Debt	-	-	-	-	-	0.27
Current Portion of Leases	2.89	1.02	1.18	1.22	1.2	1.24
Other Current Liabilities	-	2.17	1.77	14.34	2.06	2.58
Total Current Liabilities	9.89	17.8	17.83	32.44	27	30.94
Long-Term Debt	-	-	-	14.85	20.88	-
Long-Term Leases	10.91	0.01	1.02	2.01	0.25	1.12
Other Long-Term Liabilities	8.75	-0	-	-	-	0
Total Liabilities	29.55	17.81	18.86	49.3	48.12	32.07

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	93.9	9.71	9.71	6.57	6.57	5.97
Additional Paid-In Capital	-	656.29	655.9	507.2	507.2	438.83
Retained Earnings	-	-542.44	-490.55	-437.37	-387.64	-318.99
Comprehensive Income & Other	-	0.62	1.31	0.21	0.17	-0.85
Total Common Equity	93.9	124.17	176.37	76.61	126.29	124.97
Shareholders' Equity	93.9	124.17	176.37	76.61	126.29	124.97
Total Liabilities & Equity	123.45	141.98	195.22	125.91	174.41	157.04

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	13.8	1.02	2.2	18.08	22.32	2.63
Net Cash (Debt)	-7.11	32.11	73.01	-9.71	28.37	28.99
Net Cash Growth	-	-56.02%	-	-	-2.11%	216.26%
Net Cash Per Share	-0.03	0.13	0.38	-0.06	0.18	0.20
Filing Date Shares Outstanding	242.74	242.74	242.74	164.26	164.26	149.32
Total Common Shares Outstanding	242.74	242.74	242.74	164.26	164.26	149.32
Working Capital	27.08	47.23	94.16	6.34	57.85	33.84
Book Value Per Share	0.39	0.51	0.73	0.47	0.77	0.84
Tangible Book Value	31.21	60.64	112.5	12.28	61.46	59.78
Tangible Book Value Per Share	0.13	0.25	0.46	0.07	0.37	0.40
Machinery	-	24.76	26.59	24.37	23.53	18.74

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error